来自官方财务报表的收入、利润与现金流历史。
Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients, as well as new chemical entities. It also provides specialty chemicals, including photoresist chemicals for semiconductor applications; electrolyte additives for lithium battery cells; and parabens, methyl salicylate, and other commodity chemicals for cosmetics, agrochemicals, and fine chemicals.
| 利润表 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| 总收入 | ₹13.3B | ₹10.0B | ₹7.1B | ₹6.1B | — |
| 毛利 | ₹7.1B | ₹4.1B | ₹2.6B | ₹2.4B | — |
| 营业利润（EBIT） | ₹4.4B | ₹2.1B | ₹1.1B | ₹1.1B | — |
| 净利 | ₹3.6B | ₹1.6B | ₹428M | ₹833M | — |
来源：公司公开报告（SEC）。在依赖任何数字前请核对 SEC EDGAR。
资产负债表、现金流、季度数据与完整财务比率见 ACUTAAS 交互式查看器。 /companies/us/ACUTAAS
本网站信息仅用于教育与参考，不构成投资建议。不发布目标价或买卖建议。
About TickerBase · Data methodology & sources · Privacy · Terms